SSRX Related FDA
-
3SBio (SSRX) Application to Conduct China Arm of Voclosporin Phase III Approved
-
3SBio (SSRX) Receives Chinese SFDA for New EPIAO Formulation
-
3SBio (SSRX) Receives Approval for TPIAO Label Extension from China SFDA
-
3SBio (SSRX) Announces $6.25M Acquisition of Pegsiticase Rights from EnzymeRx
-
3SBio (SSRX) and Isotechnika Pharma Sign Voclosporin Development Agreement
-
3SBio (SSRX) Submits Application for NuPIAO to the Chinese SFDA
-
3SBio (SSRX) Announces Nephoxil Marketing and Development Collaboration
-
3SBio (SSRX) Submits Application to China SFDA for Feraheme Iron Therapy
-
3SBio (SSRX) Files for Chinese State FDA Approval of 36,000 IU Dosage of EPIAO
Back to SSRX Stock Lookup
